Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Rheumatology | Pediatrics/Neonatology

Arthritis and Arthritic Pain (Pediatric)

Arkansas

Little Rock : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

California

Los Angeles : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Los Angeles : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Connecticut

Hartford : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Hartford : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Florida

Delray Beach : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Miami : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Georgia

Augusta : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Illinois

Chicago : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Chicago : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Kentucky

Louisville : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Louisville : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Louisiana

New Orleans : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

New Jersey

Hackensack : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Hackensack : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Livingston : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

New York

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

Randomized Placebo Phase Study of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis (RAPPORT)

North Carolina

Durham : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Ohio

Cincinnati : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Cincinnati : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Cleveland : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Oklahoma

Oklahoma City : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Tulsa : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Texas

Houston : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Washington, DC

Washington : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Argentina

Buenos Aires : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Buenos Aires : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

La Plata : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

La Plata : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Rosario : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Tucuman : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Australia

Parkville : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Parkville : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Subiaco : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Subiaco : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Westmead : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Westmead : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Belgium

Gent : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Gent : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Leuven : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Leuven : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Brazil

Porto Alegre : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Porto Alegre : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Rio De Janeiro : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Rio De Janeiro : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Sao Paulo : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Sao Paulo : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Canada

Calgary, AB : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Halifax, NS : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Ottawa, ON : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Ottawa, ON : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Toronto, ON : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Toronto, ON : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Vancouver, BC : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Vancouver, BC : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Czech Republic

Praha : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

France

Bordeaux : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Le Kremlin Bicêtre : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Montpellier : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Paris : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Vandoeuvre Les Nancy : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Germany

Berlin : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Berlin : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Bremen : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Bremen : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Frankfurt/Main : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Sankt Augustin : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Sankt Augustin : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Greece

Athens : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Heraklion : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Ioannina : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Italy

Firenze : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Genova : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Genova : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Milano : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Milano : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Padova : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Padova : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Roma : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Roma : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Mexico

Mexico City : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Mexico City : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Monterrey : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Netherlands

Rotterdam : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Utrecht : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Utrecht : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Norway

Oslo : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Peru

Lima : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Poland

Bydgoszcz : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Kraków : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Kraków : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Lodz : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Lublin : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Lublin : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Warszawa : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Russian Federation

Moscow : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Rostov-Na-Donu : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Saint-Petersburg : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Samara : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Slovakia

Piestany : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Spain

Barcelona : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Córdoba : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Esplugas De Llobregat : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Madrid : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Madrid : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Sevilla : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Valencia : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Valencia : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

Sweden

Goeteborg : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

United Kingdom

Bristol : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Liverpool : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Liverpool : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis

London : Research Site:

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

London : Research Site:

A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis